Hypertension, Vol 23, 402-408, Copyright © 1994 by American Heart Association
T Hino, MD Nyby, M Fittingoff, ML Tuck and AS Brickman
Parathyroid hormone and parathyroid hormone-related protein lower blood
pressure and relax contracted arteries. Parathyroid hormone also attenuates
angiotensin II-induced vasoconstriction. To determine the cellular
mechanism or mechanisms by which parathyroid hormone analogues antagonize
pressor effects, we examined the effect of these peptides on angiotensin
II-induced calcium mobilization in fura 2-AM-loaded cultured rat vascular
smooth muscle cells. Either 100 nmol/L parathyroid hormone or parathyroid
hormone-related protein significantly reduced the amount of calcium
mobilized by 100 nmol/L angiotensin II. The attenuating effect of these
peptides was mimicked by 10 mmol/L forskolin and 10 mmol/L
isobutylmethylxanthine and was not dependent on the presence of
extracellular calcium. This effect of the parathyroid hormone analogues was
reduced when cells were pretreated with 100 mmol/L 2',5'-dideoxyadenosine,
an adenylate cyclase inhibitor. Combined inhibition of cyclic
nucleotide-dependent protein kinases eliminated the inhibitory effect of
parathyroid hormone, whereas protein kinase C inhibition had no effect.
Parathyroid hormone analogues decreased the amount of calcium released by
inositol 1,4,5- trisphosphate in digitonin-permeabilized vascular smooth
muscle cells. This effect was inhibited by treatment with
2',5'-dideoxyadenosine. These results suggest that these peptides attenuate
inositol 1,4,5- trisphosphate-sensitive calcium mobilized by angiotensin II
via an adenylate cyclase-dependent mechanism. This may be a mechanism by
which acute administration of parathyroid hormone or parathyroid hormone-
related peptide antagonizes vasoconstriction.
ARTICLES
Parathyroid hormone analogues inhibit calcium mobilization in cultured vascular cells
Department of Endocrinology, Veterans Affairs Medical Center, Sepulveda, CA 91343.
This article has been cited by other articles:
![]() |
S. J. Marchais, F. Metivier, A. P. Guerin, and G. M. London Association of hyperphosphataemia with haemodynamic disturbances in end-stage renal disease Nephrol. Dial. Transplant., September 1, 1999; 14(9): 2178 - 2183. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Karaki, H. Ozaki, M. Hori, M. Mitsui-Saito, K.-I. Amano, K.-I. Harada, S. Miyamoto, H. Nakazawa, K.-J. Won, and K. Sato Calcium Movements, Distribution, and Functions in Smooth Muscle Pharmacol. Rev., June 1, 1997; 49(2): 157 - 230. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |